Patent intelligence · AU
AU 7932800
Treatment of fatigue, head injury and stroke
Treatment of fatigue, head injury and stroke
Patent details — AU 7932800
- Jurisdiction
- AU
- Status
- expired
- Grant date
- Apr 23, 2001
- Expiration
- Apr 18, 2021
- Applicant
- AMARIN NEUROSCIENCE LTD
- CPC classes
- A61K 31/ 55 A I, A61K 45/ 06 A I, A61K/3155, A61K/4506
Quick answer
AU 7932800 (Treatment of fatigue, head injury and stroke) is held by AMARIN NEUROSCIENCE LTD. Status: expired. Granted Apr 23, 2001. Expires Apr 18, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AMARIN NEUROSCIENCE LTD
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 55 A I, A61K 45/ 06 A I, A61K/3155, A61K/4506, A61K9/00, A61P 43/ 00 A I
More from AMARIN NEUROSCIENCE LTD
Related pharmaceutical patents in our USPTO index.
-
CA 2754902
COMPOSES D'ACIDE GRAS ESSENTIEL
granted -
IL 159038
USE OF COENZYME Q AND EICOSAPENTAENOIC ACID (EPA) FOR THE PREPARATION OF MEDICAMENTS
granted -
DK 1007053
Behandling af smerte
granted -
CA 2591889
TRAITEMENT DE LA DEPRESSION MELANCOLIQUE SEVERE A L'AIDE D'EPA
granted -
SI 1148873
HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES FOR NEUROLOGICAL DISORDERS
expired -
IS 7744
Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi
expired -
CA 2506727
TRAITEMENT DE LA MALADIE DE HUNTINGTON AU MOYEN D'ACIDE EICOSAPENTAENOIQUE
expired -
EP 1392276
VERSTÄRKTE WIRKUNG MEHRFACH UNGESÄTTIGTER FETTSÄUREN
expired
Frequently asked questions
What is US patent 7932800?
AU 7932800 (Treatment of fatigue, head injury and stroke) is held by AMARIN NEUROSCIENCE LTD. Status: expired. Granted Apr 23, 2001. Expires Apr 18, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 7932800?
AMARIN NEUROSCIENCE LTD is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does AU 7932800 expire?
Our index shows an expiration date of Apr 18, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.